Advancing Next-Generation Bispecific Antibodies: From Rigidity to Flexibility for Differentiation & Clinical Translation
- Designing the strategy and target rationale of FlexiBody®, a multi-specific antibody platform
- Engineering considerations to optimize efficacy while mitigating on-target toxicity
- Exploring translational insights supporting clinical development and differentiation